Application 022025

Type
NDA
Sponsor
CLINIGEN

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001TOTECTDEXRAZOXANE HYDROCHLORIDEINJECTABLE;INJECTIONEQ 500MG BASE/VIALYesYes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N022025-001TOTECTDEXRAZOXANE HYDROCHLORIDEEQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTIONRLD2007-09-06

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-01 22:54:322026-06N022025-001TOTECTEQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTIONRLD2007-09-06a50c72e98297…

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 8 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
66220-110Totectdexrazoxane hydrochlorideCumberland Pharmaceuticals Inc.NDACurrent
66220-110Totectdexrazoxane hydrochlorideCumberland Pharmaceuticals Inc.NDACurrent
76310-110Totectdexrazoxane hydrochlorideCLINIGEN GROUP PLCNDACurrent
76310-110Totectdexrazoxane hydrochlorideCLINIGEN GROUP PLCNDACurrent
76310-110Totectdexrazoxane hydrochlorideCLINIGEN GROUP PLCNDACurrent
76310-110Totectdexrazoxane hydrochlorideCLINIGEN GROUP PLCNDACurrent
76310-110Totectdexrazoxane hydrochlorideClinigen LimitedNDACurrent
76310-110Totectdexrazoxane hydrochlorideCLINIGEN GROUP PLCNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
65134SUPPL2020-11-03
65127SUPPL2020-11-03
56526SUPPL2018-11-20
56504SUPPL2018-11-16
52543SUPPL2018-02-09
52523SUPPL2018-02-09
49057SUPPL2017-07-25
29101SUPPL2013-04-30
38103SUPPL2013-04-29
29100SUPPL2011-03-10
44665ORIG2009-11-24
42390ORIG2009-11-24
29099SUPPL2009-11-10
16792SUPPL2009-09-21
6714SUPPL2009-02-18
38102SUPPL2009-02-12
29098ORIG2007-09-11
16791ORIG2007-09-10